These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9591782

  • 21. Influence of Ras and retinoic acid on nerve growth factor induction of transin gene expression in PC12 cells.
    Cosgaya JM, Recio JA, Aranda A.
    Oncogene; 1997 Apr 10; 14(14):1687-96. PubMed ID: 9135070
    [Abstract] [Full Text] [Related]

  • 22. Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression.
    Conrad KE, Oberwetter JM, Vaillancourt R, Johnson GL, Gutierrez-Hartmann A.
    Mol Cell Biol; 1994 Mar 10; 14(3):1553-65. PubMed ID: 8114693
    [Abstract] [Full Text] [Related]

  • 23. Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter.
    Yu S, Zheng L, Asa SL, Ezzat S.
    Am J Physiol Endocrinol Metab; 2002 Sep 10; 283(3):E490-5. PubMed ID: 12169442
    [Abstract] [Full Text] [Related]

  • 24. The ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity.
    Conrad KE, Gutierrez-Hartmann A.
    Oncogene; 1992 Jul 10; 7(7):1279-86. PubMed ID: 1620544
    [Abstract] [Full Text] [Related]

  • 25. Regulation of the PRL promoter by Akt through cAMP response element binding protein.
    Hayakawa J, Ohmichi M, Tasaka K, Kanda Y, Adachi K, Nishio Y, Hisamoto K, Mabuchi S, Hinuma S, Murata Y.
    Endocrinology; 2002 Jan 10; 143(1):13-22. PubMed ID: 11751586
    [Abstract] [Full Text] [Related]

  • 26. A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter.
    Wang YH, Maurer RA.
    Mol Endocrinol; 1999 Jul 10; 13(7):1094-104. PubMed ID: 10406461
    [Abstract] [Full Text] [Related]

  • 27. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
    Wasylyk C, Bradford AP, Gutierrez-Hartmann A, Wasylyk B.
    Oncogene; 1997 Feb 27; 14(8):899-913. PubMed ID: 9050989
    [Abstract] [Full Text] [Related]

  • 28. Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter.
    Schweppe RE, Gutierrez-Hartmann A.
    Nucleic Acids Res; 2001 Mar 01; 29(5):1251-60. PubMed ID: 11222776
    [Abstract] [Full Text] [Related]

  • 29. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
    Chen G, Templeton D, Suttle DP, Stacey DW.
    Oncogene; 1999 Nov 25; 18(50):7149-60. PubMed ID: 10597316
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3',5'-monophosphate effects on prolactin promoter activity.
    Kievit P, Lauten JD, Maurer RA.
    Mol Endocrinol; 2001 Apr 25; 15(4):614-24. PubMed ID: 11266512
    [Abstract] [Full Text] [Related]

  • 31. An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma.
    McCracken S, Kim CS, Xu Y, Minden M, Miyamoto NG.
    Oncogene; 1997 Dec 11; 15(24):2929-37. PubMed ID: 9416836
    [Abstract] [Full Text] [Related]

  • 32. GHF-1/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element.
    Bradford AP, Conrad KE, Tran PH, Ostrowski MC, Gutierrez-Hartmann A.
    J Biol Chem; 1996 Oct 04; 271(40):24639-48. PubMed ID: 8798730
    [Abstract] [Full Text] [Related]

  • 33. Selective repression of rat prolactin gene by stable expression of dominant-negative Ets in GH4 pituitary cells.
    Tentler JJ, Bradford AP, Schweppe RE, Gutierrez-Hartmann A.
    Endocrine; 2003 Oct 04; 20(1-2):3-12. PubMed ID: 12668863
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of PI 3-kinase and RAS blocks IGF-I and insulin-induced uncoupling protein 1 gene expression in brown adipocytes.
    Teruel T, Valverde AM, Navarro P, Benito M, Lorenzo M.
    J Cell Physiol; 1998 Jul 04; 176(1):99-109. PubMed ID: 9618150
    [Abstract] [Full Text] [Related]

  • 35. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels.
    Jaggi R, Höck W, Ziemiecki A, Klemenz R, Friis R, Groner B.
    Cancer Res; 1989 Apr 15; 49(8 Suppl):2266s-2274s. PubMed ID: 2564809
    [Abstract] [Full Text] [Related]

  • 36. Phosphatidylinositol 3-kinase inhibitor wortmannin blocks mitogenic activation of the transferrin receptor gene promoter in late G1.
    Miskimins WK, King F, Miskimins R.
    Cell Growth Differ; 1997 May 15; 8(5):565-70. PubMed ID: 9149907
    [Abstract] [Full Text] [Related]

  • 37. Reversion of Ras transformed cells by Ets transdominant mutants.
    Wasylyk C, Maira SM, Sobieszczuk P, Wasylyk B.
    Oncogene; 1994 Dec 15; 9(12):3665-73. PubMed ID: 7970725
    [Abstract] [Full Text] [Related]

  • 38. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M, Darley M, Primrose JN, Blaydes JP.
    Cancer Res; 2003 May 15; 63(10):2616-23. PubMed ID: 12750288
    [Abstract] [Full Text] [Related]

  • 39. Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesis.
    Mahata SK, Mahata M, Wu H, Parmer RJ, O'Connor DT.
    Neuroscience; 1999 Jan 15; 88(2):405-24. PubMed ID: 10197763
    [Abstract] [Full Text] [Related]

  • 40. A central role for Ets-2 in the transcriptional regulation and cyclic adenosine 5'-monophosphate responsiveness of the human chorionic gonadotropin-beta subunit gene.
    Ghosh D, Ezashi T, Ostrowski MC, Roberts RM.
    Mol Endocrinol; 2003 Jan 15; 17(1):11-26. PubMed ID: 12511603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.